The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials.
Emilie H ZobelBernt Johan von ScholtenTine Willum HansenStephen C BainSøren RasmussenBenjamin WolthersPeter RossingPublished in: Diabetes, obesity & metabolism (2021)
In persons with type 2 diabetes, improvements in ≥2 risk markers conferred cardiovascular risk reduction versus none or one improved risk marker. The nephropathy risk decreased with improvement in more risk markers. These findings stress the importance of multifactorial interventions targeting all risk markers.